Lescarden has entered into an agreement with NanoASIA of Bangkok, Thailand granting the company a 10 year exclusive license to market Lescarden's proprietary product, Catrix wound dressing in Thailand and Malaysia.
Subscribe to our email newsletter
The companies are collaborating to perfect the required marketing applications to the local regulatory authorities. It is anticipated that the marketing of Catrix wound dressing will commence in the fourth quarter of 2008.
According to Lescarden, this agreement extends their penetration into the Asian market for both Catrix based clinical skin care and wound care products.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.